Colgate-Palmolive (CL) Earnings Date & Reports

Key Takeaways

• Net sales rose 4.6% to $5.37 billion, modestly above the consensus estimate of roughly $5.34 billion.
• Base Business (non-GAAP) diluted earnings per share (EPS) increased 7% to $0.97, beating the consensus estimate of $0.93, while GAAP diluted EPS rose 3% to $0.94.
• Organic sales grew 3.6%, supported by pricing up 2.0% and volume up 1.7%, with foreign exchange adding 1.0%.
• Gross profit margin expanded 80 basis points to 60.2% on a GAAP basis, and management raised its full-year margin and EPS outlook.
• North America remained a soft spot, with net sales down 1.7% and organic sales down 1.6% on a 3.7% volume decline.
• Advertising investment rose about 15% to $775 million, reflecting continued brand-building even as input costs stayed elevated.
• For more on CL, explore its Major News, Today's Price Move, Price Targets, and Forecast pages.
• Discover actionable trading ideas with Trending AI Robots.

Earnings Context and Why It Matters

Colgate-Palmolive's third-quarter report arrives at a pivotal moment for consumer packaged goods companies, which are balancing resilient pricing power against persistent volume pressure as shoppers absorb higher prices. The company has now beaten consensus EPS estimates for four consecutive quarters, signaling durable execution. Investors are watching whether broad-based category growth and productivity savings can offset elevated commodity costs, particularly resins, petrochemicals, and freight. Results across oral care, personal care, home care, and the Hill's Pet Nutrition segment matter because they reveal demand resilience and brand strength against private-label competition. Strong international momentum, led by Latin America, is being weighed against a still-soft North American market.

Reported Results

For the third quarter ended September 30, 2026, Colgate-Palmolive reported net sales of $5.37 billion, up 4.6% from $5.13 billion a year earlier and ahead of the roughly $5.34 billion consensus. Organic sales grew 3.6%, including a 0.2% negative impact from lower private-label pet food sales. Volume rose 1.7%, pricing contributed 2.0%, and foreign exchange added 1.0%.

GAAP (Generally Accepted Accounting Principles) diluted EPS increased 3% to $0.94, while Base Business (non-GAAP) diluted EPS climbed 7% to $0.97, exceeding the consensus estimate of $0.93. Net income attributable to the company rose to $751 million from $735 million. GAAP gross profit margin expanded 80 basis points to 60.2%, and Base Business gross profit margin rose 90 basis points to 60.3%. GAAP operating profit reached $1.09 billion, with an operating margin of 20.3%, down 30 basis points year over year.

Management narrowed its 2026 net sales growth outlook to 4%–5% from 2%–6%, expects organic sales growth broadly in line with its roughly 3% nine-month performance, and raised its gross profit margin and Base Business EPS growth guidance to 5%–7%. GAAP EPS is expected to grow at a double-digit rate.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Colgate-Palmolive across the consumer staples sector, it offers a faster, data-driven way to surface actionable candidates.

Market Reaction and Investor Sentiment

Colgate-Palmolive shares traded higher following the release, as investors focused on the top- and bottom-line beats and the raised profitability guidance. The 7% Base Business EPS gain and 90-basis-point Base Business gross margin expansion were seen as evidence that pricing, productivity, and favorable mix are offsetting raw material and freight inflation. Sentiment was tempered by continued weakness in North America, where a 3.7% volume decline and lower operating profit highlight a still-challenging home market. The deliberate ramp-up in advertising spending was read as a long-term investment in brand equity, though it pressured near-term margins in some regions.

Forward Outlook and Key Factors to Monitor

Following this report, investors will focus on whether Colgate-Palmolive can sustain volume growth while holding pricing, especially if consumer demand softens further. Management said commodity costs, particularly resins, petrochemicals, and pulp and paper, remain a headwind, with freight and logistics pressure expected to peak in the fourth quarter. The company's confidence in productivity programs and largely locked-in commodity costs for the balance of 2026 supports its raised guidance, but elevated input costs are expected to carry into 2027.

The North American division remains a key area to watch, given its high margins and recent volume weakness. A sustained decline there could offset gains in faster-growing regions like Latin America and in the Hill's Pet Nutrition business. Advertising investment is expected to keep rising, so investors should monitor whether increased spending translates into market share gains and durable revenue growth.

Finally, any commentary on tariffs, foreign exchange swings, and the integration of recent pet food acquisitions could shape expectations for 2027. While the company raised its outlook, the balance between pricing power and cost inflation will be central to sustaining momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations